News & Analysis on Clinical Trial Services & Contract Research And Development
Laboratory equipment maker Thermo Electron saw its Q4 net income fall 53 per cent to $56.5 (€47.2) m from $121.1 m a year ago due to one-time tax charges, but new acquisitions and a surge in demand for its instruments, particularly from its...
Pharmaceutical manufacturer Patheon has reaffirmed its dominant position in the outsourcing market with the announcement of a five-year master supply agreement with drug giant Merck.
Agilent's breakthrough HPLC-Chip technology forms the basis of its new reusable microfluidic chips, designed to compliment the company's high performance liquid chromatography (HPLC) chip/mass spectrometry (MS) modules.
Amgen are to create a European Development Centre in the UK, significantly increasing UK R&D employee numbers. Amgen's announcement echoes the UK Government's commitment to attract more R&D investment with a view to making the UK a leader in...
Biocrystal has upped the stakes in the cell culture market with Opticell, a product it claims brakes away from traditional cell culture concepts and promises to reduce costs through increased efficiency.